Cite
MLA Citation
Vissia Viglietta et al.. “[P1–053]: CHANGE FROM BASELINE IN CLINICAL DEMENTIA RATING SCALE COGNITIVE AND FUNCTIONAL DOMAINS IN PRIME, A RANDOMIZED PHASE 1B STUDY OF THE ANTI–AMYLOID BETA MONOCLONAL ANTIBODY ADUCANUMAB (BIIB037).” Alzheimer's & dementia, vol. 13, n.d., pp. P256–P257. http://access.bl.uk/ark:/81055/vdc_100102561122.0x00000e